Alzheimer’s drug lecanemab receives accelerated FDA approval amid safety concerns January 8, 2023January 7, 2023
FDA grants priority review to Pfizer/BioNTech Covid-19 vaccine; decision on approval expected by January 2022 July 16, 2021July 16, 2021